Adding Sarclisa to Treatment– A Promising New Option for Relapsed Multiple Myeloma

Adding Sarclisa to Treatment– A Promising New Option for Relapsed Multiple Myeloma

NOW
PLAYING
New PARP Inhibitor Combination Approved for Ovarian Cancer
NOW
PLAYING
$21 Billion Bet On Cancer Drug Trodelvy: What Does It Mean for Patients?
NOW
PLAYING
Which Women with Ovarian Cancer Should Get PARP Inhibitors? New Guidelines Offer Recommendations
NOW
PLAYING
New Lung Cancer Drug, Retevmo, So Effective It Gave Musician His Life Back
NOW
PLAYING
Revolution in Lung Cancer Drugs Extends Life
NOW
PLAYING
PARP Inhibitor Side Effects
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.